Bernard J. Zovighian is CEO at Edwards Lifesciences Corp (EW). They have made 8 open-market trades across 1 company since 2017, most recently 2026-07-27.
CIK 0001665141
1 open-market purchase totalling $50K since 2024, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EW | 8,915 | $772K |
Shares reported on the most recent Form 4, priced at the 2026-07-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EW | SELL | 2026-07-27 | 2026-07-27 | $83.95 | $245K | +6.2% | +8.0% | — |
| EW | SELL · 10b5-1 | 2026-06-17 | 2026-06-17 | $87.92 | $46K | +3.8% | -1.7% | -1.6% |
| EW | SELL · 10b5-1 | 2026-05-12 | 2026-05-12 | $77.93 | $2.8M | +8.6% | +8.6% | +16.4% |
| EW | SELL | 2026-02-12 | 2026-02-13 | $76.67 | $1.7M | +11.3% | +8.2% | +5.4% |
| EW | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $84.94 | $4.3M | +2.6% | +0.9% | +1.7% |
| EW | SELL · 10b5-1 | 2025-05-30 | 2025-06-03 | $77.22 | $2.6M | -2.5% | -0.3% | +6.1% |
| EW | SELL · 10b5-1 | 2025-05-05 | 2025-05-06 | $74.91 | $896K | +4.2% | +3.9% | +7.0% |
| EW | SELL · 10b5-1 | 2025-03-10 | 2025-03-10 | $69.51 | $857K | +4.0% | +2.4% | +11.9% |
| EW | SELL · 10b5-1 | 2024-05-30 | 2024-05-30 | $87.68 | $1.5M | -0.8% | +2.9% | -21.7% |
| EW | BUY | 2024-05-06 | 2024-05-07 | $85.78 | $50K | +4.0% | +2.3% | -29.2% |
| EW | SELL | 2022-08-05 | 2022-08-05 | $103.66 | $997K | -5.9% | -16.6% | -35.7% |
| EW | SELL | 2022-06-14 | 2022-06-14 | $87.75 | $844K | +10.2% | +10.4% | +10.9% |
| EW | SELL | 2022-05-31 | 2022-05-31 | $100.83 | $907K | -8.1% | -6.0% | -10.7% |
| EW | SELL | 2022-05-24 | 2022-05-24 | $95.52 | $919K | +2.3% | -0.6% | +1.8% |
| EW | SELL | 2017-04-27 | 2017-04-28 | $109.21 | $3.9M | +0.7% | +4.3% | +5.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.